FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) from Kenvue Brands LLC, under NDA 020325.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• PEPCID AC MAXIMUM STRENGTH (FAMOTIDINE)

Snippet

SUPPL AP for PEPCID AC MAXIMUM STRENGTH (FAMOTIDINE)